Attempting to inject semaglutide into muscle tissue would fundamentally alter how your body processes the compound and could lead to unpredictable side effects or reduced efficacy
The relationship between stress and fibromyalgia is particularly noteworthy, with a significant number of patients reporting the onset of symptoms after a period of severe emotional stress or trauma
Scientists are continuing to investigate its pharmacokinetics, metabolic pathways, long-term safety profile, and regulatory toxicology, but translating findings from laboratory and animal models into human applications is a significant challenge
These effects typically emerge during dose escalation periods
Common GLP-1 medications available in the UK include: GLP-1 receptor agonists: Semaglutide (Ozempic for diabetes, Wegovy for weight management) Liraglutide (Victoza for diabetes, Saxenda for weight management) Dulaglutide (Trulicity for diabetes) Dual GIP/GLP-1 receptor agonist: Tirzepatide (Mounjaro for diabetes, Zepbound for weight management) These medications are administered via subcutaneous injection, typically weekly or daily depending on the specific formulation
Within a day of injecting, most of the medication would be gone